Induction of inducible nitric oxide synthase by lipopolysaccharide/ interferon gamma and sepsis down-regulates 5-lipoxygenase metabolism in murine alveolar macrophages

Experimental Lung Research

Volumn 30, Issue 7, 2004, Pages 615-633

  Coffey, Michael J ^a   Phare, Susan M ^a   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Eicosanoid; Endotoxin; Leukotriene; Peritonitis; Reactive nitrogen intermediate

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOTRIENE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME METABOLISM; ENZYME REPRESSION; FEMALE; KNOCKOUT MOUSE; LIGATION; LIPOGENESIS; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS; WILD TYPE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CECUM; DOWN-REGULATION; ENZYME INDUCTION; FEMALE; INTERFERON TYPE II; LEUKOTRIENES; LIGATION; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SEPSIS; SPECIFIC PATHOGEN-FREE ORGANISMS; WOUNDS, STAB;

EID: 4444353378     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490476391     Document Type: Article

References (47)

1. Levin J, Poore T, Zauber N, Oser R: Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria. N Engl J Med. 1970;283:1313-1316.
2. Bone R, Fisher C Jr, Clemmer T, Slotman G, Metz C, Balk R: Sepsis syndrome: a valid clinical entity: Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1989; 17:389-393.
3. Niederman M, Fein A: Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: a common clinical sequence. Clin Chest Med. 1990;11:633-656.
4. Zhang P, Bagby G, Stoltz D, Summer W, Nelson S: Enhancement of peritoneal leukocytes function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit Care Med. 1998;26:315-321.
5. Dixon RA, Diehl RE, Opas E, et al: Requirement of a 5-lipoxygenase- activating protein for leukotriene synthesis. Nature. 1990;343:282-284.
6. Ford-Hutchinson AW: Modification of the lipoxygenase pathway of arachidonic acid metabolism. In: Samuelsson B, et al, eds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Vol. 20. New York: Raven Press; 1990:161-169.
7. Samuelsson B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983;220:568-575.
8. Lewis R, Austen K, Soberman R: Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human disease. N Engl J Med. 1990;323:645-655.
9. Drazen J, Israel E, O'Byrne P: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999;340:197-206.
10. Stephenson A, Lonigro A, Hyers T, Webster R, Fowler A: Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or risk of ARDS. Am Rev Respir Dis. 1988;138:714-719.
11. Hopkins H, Stull T, Von Essen S, Robbins R, Rennard S: Neutrophil chemotactic factors in bacterial pneumonia. Chest. 1989;95:1021-1027.
12. 4. Int J Immunopharmacol. 1989;11:801-808.
13. Bailie M, Standiford T, Laichalk L, Coffey M, Strieter R, Peters-Golden M: Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol. 1996;157:5221-5224.
14. Mancuso P, Standiford T, Marshall T, Peters-Golden M: 5-lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun. 1998;66:5140-5146.
15. Moncada S, Palmer R, Higgs E: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
16. Gaston B, Drazen J, Loscalzo J, Stamler J. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994;149:538-551.
17. Raychaudhuri B, Dweik R, Connors M, et al: Nitric Oxide blocks nuclear factor-κB activation in alveolar macrophages. Am J Respir Cell Mol Biol. 1999;21:311-316.
18. Rovira I: Use of nitric oxide in acute respiratory failure. Clin Pulm Med. 1999;6:187-194.
19. Salvemini D, Misko T, Masferrer J, Seibert K, Currie M: Nitric Oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 1993;90:7240-7244.
20. Feng L, Xia Y, Garcia G, Hwang D, Wilson C: Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest. 1995;95:1669-1675.
21. Stadler J, Harbrecht B, DiSilvio M, et al: Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin 6 by rat Kupffer cells. J Leukoc Biol. 1993;53:165-172.
22. Coffey M, Phare S, Peters-Golden M: Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J Immunol. 2000;165:3592-3598.
23. Coffey M, Peters-Golden M, Fantone J, Sporn P: Membrane association of active 5-lipoxygenase in resting cells: evidence for novel regulation of the enzyme in the rat alveolar macrophage. J Biol Chem. 1992;267:570-576.
24. Peters-Golden M, McNish RW, Hyzy R, Shelly C, Toews GB: Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J Immunol. 1990;144:263-270.
25. Kristof A., Goldberg P, Laubach V, Hussain S: Role of inducible nitric oxide synthase in endotoxin-indueed acute lung injury. Am J Respir Crit Care Med. 1998;158:1883-1889.
26. Coffey M, Wilcoxen S, Peters-Golden M: Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism which accompanies differentiation of peripheral blood monocytes into alveolar macrophages. Am J Respir Cell Mol Biol. 1994;11:153-158.
27. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685..
28. Buccellati C, Rossoni G, Bonazzi A, et al: Nitric oxide modulation of transcellular biosynthesis of cys-leukotrienes in rabbit leukocyte-perfused heart. B J Pharmacol. 1997;120:1128-1134.
29. 6-(l-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem. 1994;37:3886-3888.
30. Coffey M, Phare S, Peters-Golden M: Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther. 2001;299:198-203.
31. Martin E, Nathan C, Xie Q. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994;180:977-984.
32. 4 release from alveolar macrophages. Eur J Pharmacol. 1997;326:53-60.
33. Coffey M, Phare S, Peters-Golden M. Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta. 2002;1584:81-90.
34. Bergamini A, Bolacchi F, Bongiovanni B, et al: Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. Immunology. 2000;101:254-261.
35. Ring W, Riddick C, Baker J, Munafo D, Bigby T: Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukih 3. J Clin Invest. 1996;97:1293-1301.
36. Coffey M, Phare S, Cinti S, Peters-Golden M, Kazanjian P: Granulocyte-macrophage colonizing-stimulating factor upregulates the defect in 5-lipoxygenase metabolism in neutrophils and monocytes in AIDS. Blood. 1999;94:3897-3905.
37. Meslier N, Aldrich A, Bigby T: Effect of interferon-gamma on the 5-lipoxygenase pathway of rat lung macrophages. Am J Respir Cell Mol Biol. 1992;6:93-99.
38. Stokes K, Clanton E, Clements K, Granger D: Role of interferon-gamrna in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation. 2003;107:2140-2145.
39. Brock T, McNish R, Bailie M, Peters-Golden M: Rapid import of cytosolic 5-lipoxygenase into the nucleus of neutrophils after in vivo recruitment and in vitro adherence. J Biol Chem. 1997;272:8276-8280.
40. Yin K, Hock C, Lai P, Ross J, Yue G. Role of interferon-gamma in lung inflammation following cecal ligation and puncture in-rats. Shock. 1999;12:215-221.
41. Okamoto I, Abe M, Shibata K, et al: Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med. 2000;162:716-722.
42. Benjamim C, Ferreira S, Cunha F: Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis. 2000;182:214-223.
43. Benjamim C, Silva J, Fortes Z, Oliveira M, Ferreira S, Cunha F: Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun. 2002;70:3602-3610.
44. Goya T, Abe M, Shimura H, Torisu M: Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol. 1992;52:236-243.
45. Rios-Santos F, Benjamim C, Zavery D, Ferreira S, Cunha F: A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. Shock. 2003;19:61-65.
46. Brock T, McNish R, Mancuso P, Coffey M, Reters-Golden M: Prolonged lipopolysaccharide inhibits leukotriene synthesis in peritoneal macrophages:mediation by nitric oxide and prostaglandins. Prostaglandins and Other Lipid Mediators 2003;71:131-145.
47. Fermor B, Haribabu B, Weinberg JB, Pisetsky DS, Guilak F: Mechanical stress and nitric oxide influence leukotriene production in cartilage. Biochem Biophys Res Commun. 2001;285:806-810.